SECURED PROMISSORY NOTE
This Amendment to Secured Promissory Note (this Amendment) is made and entered into as of May 10, 2021 (the Amendment Effective Date) by and between Interpace Biosciences, Inc., a Delaware corporation (the Borrower), and Ampersand 2018 Limited Partnership, a Delaware limited partnership (the Noteholder). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Note (as defined below).
WHEREAS, the Borrower has entered into that certain Secured Promissory Note dated as of January 7, 2021 (the Note), made in favor of the Noteholder, in the aggregate principal amount of $3,000,000.00 (the Original Amount);
WHEREAS, pursuant to Section 12.11 of the Note, any term of the Note may be amended or modified with the written consent of the Borrower and the Noteholder; and
WHEREAS, the Borrower and Noteholder desire to amend the Note to increase the aggregate principal amount of the Original Amount by $1,500,000.00 (the Additional Amount) as further described herein.
NOW, THEREFORE, in accordance with the foregoing and intending to be legally bound hereby, the Borrower and the Noteholder hereby amend the Note as provided for below, and otherwise further agree as follows:
1. Amendment to the Note. The Note is hereby amended as follows:
(a) The principal amount as stated on the first page of the Note underneath the heading Secured Promissory Note is hereby amended by (i) deleting the word $3,000,000.00 and (ii) adding the word $4,500,000.00 in its place;
(b) The principal amount as stated in the first clause of the Note is hereby amended by (i) deleting the word $3,000,000.00 and (ii) adding the word $4,500,000.00 in its place;
(c) The defined term Loan is hereby amended by (i) deleting the word $3,000,000.00 and (ii) adding the word $4,500,000.00 in its place;